Hypophosphataemic rickets is a rare, genetic disorder resulting in defect bone mineralisation and rickets. The current medical treatment consists of phosphate supplementation and alfacalcidol, but side effects such as secondary hyperparat-hyroidism and nephrocalcinosis are common. This treatment regimen often fails to prevent bone deformity and reduced final height. The rarity and complexity of these diseases call for centralised specialist care and international collaboration. Future medical treatment may be improved by addition of new promising experimental treatments.
|Bidragets oversatte titel||Medical treatment of children with hypophosphataemic rickets.|
|Tidsskrift||Ugeskrift for Laeger|
|Status||Udgivet - 24. feb. 2014|